Showing 1 - 4 results of 4 for search 'Wendy J. C. Prager‐van der Smissen', query time: 0.03s
Refine Results
-
1
A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity by Teoman Deger, Pauline A. J. Mendelaar, Jaco Kraan, Wendy J. C. Prager‐van der Smissen, Michelle van derVlugt‐Daane, Eric M. J. Bindels, Anieta M. Sieuwerts, Stefan Sleijfer, Saskia M. Wilting, Antoinette Hollestelle, John W. M. Martens
Published 2022-08-01
Article -
2
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile by Marcel Smid, Marjanka K. Schmidt, Wendy J. C. Prager-van der Smissen, Kirsten Ruigrok-Ritstier, Maartje A. C. Schreurs, Sten Cornelissen, Aida Marsal Garcia, Annegien Broeks, A. Mieke Timmermans, Anita M. A. C. Trapman-Jansen, J. Margriet Collée, Muriel A. Adank, Maartje J. Hooning, John W. M. Martens, Antoinette Hollestelle
Published 2023-05-01
Article -
3
Functional Homologous Recombination (HR) Screening Shows the Majority of <i>BRCA1/2</i>-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient by Titia G. Meijer, John W. M. Martens, Wendy J. C. Prager-van der Smissen, Nicole S. Verkaik, Corine M. Beaufort, Stanley van Herk, Teresa Robert-Finestra, Remco M. Hoogenboezem, Kirsten Ruigrok-Ritstier, Maarten W. Paul, Joost Gribnau, Eric M. J. Bindels, Roland Kanaar, Agnes Jager, Dik C. van Gent, Antoinette Hollestelle
Published 2024-02-01
Article -
4
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a <i>BRCA1/2</i> Mutation by Shuoying Qu, A. Mieke Timmermans, Bernadette A. M. Heemskerk-Gerritsen, Anita M. A. C. Trapman-Jansen, Renée Broeren-Foekens, Wendy J. C. Prager-van der Smissen, Hoesna El Hassnaoui, Tim van Tienhoven, Claudia K. Bes-Stobbe, Pieter J. Westenend, Carolien H. M. van Deurzen, John W. M. Martens, Maartje J. Hooning, Antoinette Hollestelle
Published 2023-12-01
Article